BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lochan R, Daly AK, Reeves HL, Charnley RM. Genetic susceptibility in pancreatic ductal adenocarcinoma. Br J Surg 2008;95:22-32. [PMID: 18076020 DOI: 10.1002/bjs.6049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Chun SG, Yee NS. Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy. Cancer Biol Ther. 2010;10:430-437. [PMID: 20657174 DOI: 10.4161/cbt.10.5.12763] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
2 Gouma DJ, Busch OR, van Gulik TM. Treatment of Pancreatic Adenocarcinoma: A European Perspective. Surgical Oncology Clinics of North America 2008;17:569-86. [DOI: 10.1016/j.soc.2008.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Navarro S, Vaquero E, Maurel J, Bombí JA, De Juan C, Feliu J, Fernández Cruz L, Ginés À, Girela E, Rodríguez R, Sabater L. Recomendaciones para el diagnóstico, la estadificación y el tratamiento del cáncer de páncreas (parte I). Medicina Clínica 2010;134:643-55. [DOI: 10.1016/j.medcli.2009.12.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst. 2009;101:424-431. [PMID: 19276450 DOI: 10.1093/dnci/djp020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ozhan G, Yanar HT, Ertekin C, Alpertunga B. Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis. Mediators Inflamm 2010;2010:482950. [PMID: 20396411 DOI: 10.1155/2010/482950] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
6 Lochan R, Daly AK, Reeves HL, Charnley RM. Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma. J Oncol. 2011;2011:215985. [PMID: 21547248 DOI: 10.1155/2011/215985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
7 Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31. [PMID: 19276450 DOI: 10.1093/jnci/djp020] [Cited by in Crossref: 216] [Cited by in F6Publishing: 187] [Article Influence: 16.6] [Reference Citation Analysis]
8 Vrana D, Pikhart H, Mohelnikova-Duchonova B, Holcatova I, Strnad R, Slamova A, Schejbalova M, Ryska M, Susova S, Soucek P. The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res 2009;680:78-81. [PMID: 19786118 DOI: 10.1016/j.mrgentox.2009.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
9 Lochan R, Reeves HL, Daly AK, Charnley RM. The role of tobacco-derived carcinogens in pancreas cancer. ISRN Oncol 2011;2011:249235. [PMID: 22084727 DOI: 10.5402/2011/249235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Sakorafas GH, Tsiotos GG, Korkolis D, Smyrniotis V. Individuals at high-risk for pancreatic cancer development: management options and the role of surgery. Surg Oncol 2012;21:e49-58. [PMID: 22244849 DOI: 10.1016/j.suronc.2011.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Özhan G, Lochan R, Leathart JB, Charnley R, Daly AK. Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility. Pancreas 2011;40:1289-94. [PMID: 21705955 DOI: 10.1097/MPA.0b013e31821fcc3b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chen J, Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas 2011;40:872-5. [PMID: 21697764 DOI: 10.1097/MPA.0b013e318219dafe] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Pang L, Word B, Xu J, Wang H, Hammons G, Huang SM, Lyn-Cook B. ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance? Gastroenterol Res Pract 2014;2014:414931. [PMID: 24883056 DOI: 10.1155/2014/414931] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]